Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

#Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Size And Revenue Forecast Through 2030

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market has demonstrated rapid expansion in recent years. This market is expected to grow from $0.62 billion in 2025 to $0.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.2%. Historically, this expansion can be attributed to the rising prevalence of chronic and complex diseases, the increased adoption of advanced diagnostic imaging technologies, greater investment in precision medicine research initiatives, the broader application of genomic sequencing and molecular profiling, and the escalating demand for data-driven clinical decision-making solutions.

The artificial intelligence (AI)-powered diagnostic radiogenomics devices market is projected for significant expansion in the coming years, with its size expected to reach $1.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 19.5%. This notable growth is largely attributable to several factors, including the increasing demand for AI-enabled personalized treatment planning solutions, the rising adoption of cloud-based radiogenomic data analytics platforms, the growing integration of genomics into diagnostic imaging workflows, a surge in investment towards oncology and neurology precision diagnostics, and a heightened focus on early disease detection and predictive healthcare technologies. Furthermore, major trends anticipated during this forecast period encompass the increasing adoption of multimodal imaging and genomics integration platforms, a growing demand for personalized and precision diagnostic solutions, the rising utilization of predictive analytics for disease prognosis and therapy response assessment, the increasing implementation of automated radiogenomic data interpretation tools, and an expanding emphasis on real-time clinical decision support within diagnostic workflows.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample_request?id=48488920&type=smp

#Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing use of precision medicine approaches is projected to drive the expansion of the AI-powered diagnostic radiogenomics devices market in the coming years. Precision medicine refers to medical strategies that customize disease prevention, diagnosis, and treatment based on individual genetic, environmental, and lifestyle differences. The rise in precision medicine adoption is primarily fueled by the growing incorporation of genomic data into clinical decision-making within advanced healthcare systems. AI-powered diagnostic radiogenomics devices support this development by combining medical imaging with genomic data to facilitate accurate disease profiling, early diagnosis, and personalized treatment planning. For instance, in February 2024, a report from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, highlighted that more than one-third of new drug approvals by the U. S. Food and Drug Administration were personalized therapies for four consecutive years through 2023. Therefore, the increasing embrace of precision medicine approaches is stimulating the growth of the AI-powered diagnostic radiogenomics devices market.

Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Segmentation: How Is The Market Structured Across Key Categories?

The artificial intelligence (ai)-powered diagnostic radiogenomics devices market covered in this report is segmented –

1) By Component: Hardware, Software, Services

2) By Imaging Modality: Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Ultrasound, X-Ray Or Mammography, Multi-Modal Fusion

3) By Application: Oncology, Neurology, Cardiology, Infectious Diseases

4) By End User: Hospitals And Clinics, Diagnostic Imaging Centers, Academic And Research Institutes And Biobanks, Pharmaceutical And Biotechnology Companies And Contract Research Organizations, Government And Public Health Programs

Subsegments:

1) By Hardware: Imaging Sensors, Computational Processing Units, Data Storage Systems, Networking And Connectivity Modules, User Interface Devices

2) By Software: Radiogenomic Analysis Software, Artificial Intelligence Diagnostic Algorithms, Image Processing And Enhancement Software, Data Visualization And Reporting Tools, Machine Learning Model Management Software

3) By Services: Installation And Setup Services, Calibration And Maintenance Services, Training And Support Services, Data Management And Integration Services, Clinical Workflow Optimization Services

Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Industry Trends: What Changes Are Reshaping Demand?

Leading companies in the AI-powered diagnostic radiogenomics devices market are increasingly prioritizing technological innovations, particularly imaging quality assessment tools, to boost diagnostic precision and consistency. An imaging quality assessment tool operates as a software system, employing advanced algorithms to appraise, standardize, and ensure the dependability of medical imaging information. For instance, in June 2025, Quibim, a medical imaging technology company from Spain, introduced AI-QUAL. This solution uses artificial intelligence to automatically evaluate the quality of prostate magnetic resonance imaging, assign standardized scores, and identify artifacts that could affect diagnostic outcomes. The tool streamlines radiology workflows and aids in more reliable clinical decision-making by guaranteeing high-quality imaging data, which is crucial for subsequent applications such as radiogenomics.

Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Competitive Landscape And Leading Companies

Major companies operating in the artificial intelligence (ai)-powered diagnostic radiogenomics devices market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Philips Healthcare (Koninklijke Philips N. V. ), GE HealthCare Technologies Inc., Agilent Technologies Inc., Canon Medical Systems Corporation, Tempus AI Inc., Aidoc Medical Ltd., Owkin Inc., SOPHiA GENETICS SA, Lunit Inc., Synaptive Medical Inc., Median Technologies SA, Perspectum Ltd., Quibim S. L., Seno Medical Instruments Inc., Ultromics Limited, QMENTA Inc., Imbio LLC, Mirada Medical Limited, VUNO Inc., Radiomics. bio Inc., Qlucore AB, CureMetrix Inc.

Access The Complete Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-powered-diagnostic-radiogenomics-devices-market-report

Artificial Intelligence (AI)-Powered Diagnostic Radiogenomics Devices Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered diagnostic radiogenomics devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model